Actively Recruiting
68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
Led by The First Affiliated Hospital of Xiamen University · Updated on 2025-02-19
90
Participants Needed
1
Research Sites
188 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the diagnostic efficacy of 68Ga FAPI PET/CT in myelofibrosis and to identify fibrosis grades. To evaluate the diagnostic efficacy of 68Ga FAPIPET/CT imaging in patients with myelofibrosis, compared with conventional CT.
CONDITIONS
Official Title
68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients with suspected or confirmed myelofibrosis, or primary/secondary myelofibrosis not treated with ruxolitinib
- Expected survival time over 3 months
- Voluntarily signed informed consent
- Willing and able to follow the research protocol
- Able to lie on the scanning bed for 20 minutes
You will not qualify if you...
- Known allergy to 68Ga FAPI or its excipients
- Unable to tolerate intravenous drug administration (e.g., history of needle or blood fainting)
- Unable or unsuitable to complete PET imaging due to reasons like claustrophobia or radiophobia
- Pregnant or breastfeeding women
- Long-term exposure to radiation at work
- Serious diseases of heart, kidney, lung, blood vessels, nervous system, mental system, immune deficiency, or hepatitis/cirrhosis
- Participation in other interventional clinical trials within 1 month before screening
- Undergoing chemotherapy, immunotherapy, or targeted therapy for other cancers
- Other conditions deemed unsuitable by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bing Xu
Xiamen, Fujian, China, 361000
Actively Recruiting
Research Team
B
Bing Xu
CONTACT
L
Long Liu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here